P
78.26
1.47 (1.91%)
| 前收盘价格 | 76.79 |
| 收盘价格 | 77.93 |
| 成交量 | 3,214 |
| 平均成交量 (3个月) | 6,874 |
| 市值 | 16,386,623,488 |
| 市盈率 (P/E TTM) | 14.69 |
| 52周波幅 | |
| 利润日期 | 30 Oct 2025 |
| 股息率 (DY TTM) | 1.08% |
| 营业毛利率 | 11.31% |
| 营业利益率 (TTM) | -7.94% |
| 稀释每股收益 (EPS TTM) | 5.03 |
| 季度收入增长率 (YOY) | 2.30% |
| 季度盈利增长率 (YOY) | 156.70% |
| 总债务/股东权益 (D/E MRQ) | 26.30% |
| 流动比率 (MRQ) | 2.97 |
| 营业现金流 (OCF TTM) | -9.56 M |
| 杠杆自由现金流 (LFCF TTM) | -23.91 M |
| 资产报酬率 (ROA TTM) | 1.44% |
| 股东权益报酬率 (ROE TTM) | 10.19% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (GB) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | PHARMA MAR SA PHARMA MAR ORD SH | - | - |
AIStockmoo 评分
0.0
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 1.5 |
| 平均 | 0.00 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
|
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 29.37% |
| 机构持股比例 | 8.67% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合